LianBio News

News On LianBio (LIAN) Now Under LIANY

News On LianBio (LIAN) Now Under LIANY

Dow JonesMar 19 17:08 ET

What's Going On With LianBio (LIAN) Stock?

LianBio – ADR (NASDAQ:LIAN) shares are trading higher by some 84% to $0.35 Friday afternoon on continued volatility. The company in late February announced its intent to delist its American Depositary

BenzingaMar 15 15:44 ET

LianBio Announces Voluntarily Delisting From Nasdaq

SHANGHAI, China and PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN) ("LianBio" or the "Company"), a biotechnology company dedicated to bringing innovative medicines to pati

GlobeNewswireFeb 28 07:00 ET

LianBio Declares $4.80 Special Dividend

Seeking AlphaFeb 15 02:28 ET

LianBio To Go Ex-Dividend On March 15th, 2024 With 4.8 USD Special Dividend Per Share

February 15th - $LianBio(LIAN.US)$ is trading ex-dividend on March 15th, 2024. Shareholders of record on February 27th, 2024 will receive 4.8 USD special dividend per share on March 14th, 2024. Th

moomoo NewsFeb 14 19:40 ET

Express News | LianBio Shares Are Trading Higher After the Company Completed Its Strategic Review and Determined to Initiate the Wind Down of Its Operations, Including the Sale of Remaining Pipeline Assets, Delisting of ADS and Workforce Reductions. Also, the Company De

Moomoo 24/7Feb 13 11:43 ET

Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. Shares of Ecolab Inc. (NYSE:ECL) rose during Tuesday's session after the company reported better-than-expecte

BenzingaFeb 13 10:09 ET

LianBio to Start Wind Down Operations; Complete Dissolution Expected in 2027

LianBio (LIAN) said Tuesday that its board has decided to wind down its operations, which it expects to be "substantially" completed by the end of the year. Complete dissolution is expected to take pl

MT NewswiresFeb 13 09:36 ET

LianBio Announces Wind Down Of Operations, Workforce Reduction; Stock Up In Pre-Market

RTTNewsFeb 13 09:26 ET

LianBio to Wind Down Its Operations, Delist Its ADS; Shares up

Seeking AlphaFeb 13 08:34 ET

LianBio Shares Gain After Co Announces Plans to Wind Down

By Mary de Wet LianBio shares were up nearly 17% in premarket trading Tuesday after the troubled biotechnology company said it would wind down its operations. The American Depositary Shares recently

Dow JonesFeb 13 08:28 ET

Express News | LianBio Completes Strategic Review And Determined To Initiate The Wind Down Of Its Operations, Including Sale Of Remaining Pipeline Assets, Delisting Of ADSs And Workforce Reductions; Board Has Declared Special Dividend Of $4.80/Sharea

Moomoo 24/7Feb 13 07:09 ET

LianBio Announces Completion of Strategic Review

LianBio to commence the wind down of its operations, including sale of remaining assets and reduction in force, delisting from Nasdaq and issuance of special cash dividendSHANGHAI, China and PRINCETON

GlobeNewswireFeb 13 07:00 ET

LianBio Cut to Underperform From Buy by B of A Securities

LianBio Cut to Underperform From Buy by B of A Securities

Dow JonesJan 3 09:19 ET

B of A Securities Downgrades LianBio to Underperform, Lowers Price Target to $3

B of A Securities analyst Geoff Meacham downgrades LianBio (NASDAQ:LIAN) from Buy to Underperform and lowers the price target from $5 to $3.

BenzingaJan 3 09:09 ET

Express News | Pursuant To The APA, LianBio Development Will Receive A Payment Of $25M; Eligible To Receive A Sales Milestone Payment Of $5M Within 60 Days After The End Of The First Calendar Year If Net Sales Of The Licensed Products In China Exceed $20M

Moomoo 24/7Dec 26, 2023 16:16 ET

Express News | On Dec 22, LianBio Development Limited, Janssen Pharmaceutica Nv, LianBio Entered Into An Asset Purchase Agreement; LianBio Development, Certain Affiliates Will Sell To Janssen All Of Seller Entities' Rights, Tile Interests In Products Licensed To Unit

Moomoo 24/7Dec 26, 2023 16:13 ET

Sector Update: Health Care Stocks Mixed Premarket Tuesday

Health care stocks were mixed premarket Tuesday as the Health Care Select Sector SPDR Fund (XLV) was marginally lower and iShares Biotechnology ETF (IBB) was up 0.8% recently. Bristol-Myers Squibb (BM

MT NewswiresDec 26, 2023 09:14 ET

LianBio Assigns Rights to Nanobiotix's Oncology Therapy in China, Other Asian Markets to Janssen Pharmaceutica

LianBio (LIAN) said Tuesday it has assigned to Johnson & Johnson's (JNJ) Janssen Pharmaceutica subsidiary the exclusive rights to develop and commercialize investigational oncology product NBTXR3 in China, South Korea, Singapore and Thailand.

MT NewswiresDec 26, 2023 03:35 ET

LianBio Enters Into Agreement With Janssen Pharmaceutical, Assigns NBTXR3 Rights In China And Other Asian Markets For $25M

LianBio announced that the company has entered into an agreement with Janssen Pharmaceutica NV ("Janssen"), a Johnson & Johnson company, whereby Lian has assigned to Janssen LianBio's exclusive rights

BenzingaDec 26, 2023 02:16 ET